U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data ...

Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.

The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad.

Lynozyfic’s global sales are projected to reach $707 million by 2031.

Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...

China's biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds ...

DHAKA, June 15, 2025 (BSS)- In the wake of the emergence of a new COVID strain, health experts have urged the public to ...

The decision of the General Court of the European Union in the Pfizergate case would allow the European Commission to ...

Obesity is a growing health problem around the world. It raises the risk of many serious conditions, including heart disease, ...

China's biotechnology sector is experiencing notable growth, with the ChinaAMC Hang Seng Biotech ETF, tracking the Hang Seng ...